Overview
In collaboration with Regenerus Labs, watch James Neuenschwander, MD (Dr. Neu) in a one-hour presentation on how to diagnose a mold-toxic patient starting with when to suspect that mycotoxins might be a part of your patient’s symptom survey or routine lab results.
Using real-world examples, he will guide you through identifying the source of mold, detoxifying the mycotoxins from an individual, and using the OAT and MycoTOX Profile as surveillance tools to monitor progress and determine the appropriate treatment program.
He will also cover some of the basics behind treating sequelae of prolonged mycotoxin illness like mast cell activation syndromes and autonomic dysfunction.
Objectives
At the end of this presentation, participants should be able to:
- Identify signs, symptoms, and findings on routine labs that should alert them to the possibility of a mold-toxic patient.
- Recognize the markers on an organic acid test (OAT) that would suggest toxicity.
- Use a mycotoxin screen to identify patients that have an exposure to mycotoxins.
- Differentiate between a patient that has mold colonization and one that does not.
- Identify the tools that can be used to determine if a patient with mycotoxins in their urine is symptomatic from those mycotoxins.
- Review the use of binders to remove mycotoxins.
- Identify patients who would benefit from the use of antifungals.
- Review the detox pathways and identify ways to support them.
About the Author
James Neuenschwander, MD
Dr. Neu is board-certified in Emergency Medicine, Integrative and Holistic Medicine, as well as Anti-Aging and Regenerative Medicine. In addition, he is a Fellow of the American Academy of Anti-Aging Medicine (A4M) and holds a certification in chelation therapy. He is a member of A4M, ACAM, and ILADS. He has been a DAN! Practitioner since 2007 and a member of Medical Academy of Pediatric Special Needs (MAPS) since its founding. His private practice is in Ann Arbor, Michigan.
You Might Also Like
View All Webinars
Indicators of Detoxification: The Assessment of Pyroglutamic Acid
In assessment of the Organic Acid Test (OAT), a beneficial section is the “Indicators of Detoxification,” The first marker found in this section, marker 58, gives insight into detoxification and glutathione synthesis.
Beyond The Gut: The Relationship Between Gluten, Psychosis, and Schizophrenia
The National Institutes for Mental Health provide a succinct definition for schizophrenia as periods of psychosis characterized by disturbances in thought and perception and disconnections from reality; however, diagnosis is much less straightforward. Schizophrenia represents a wide illness spectrum with symptomatic features and severity ranging from odd behavior to paranoia. With a prevalence rate over the past century holding steady at 1% worldwide and immovably poor patient outcomes, schizophrenia delivers profound relational and societal burdens, proving to be a complex clinical challenge and an unyielding epidemiological obstacle.
Gluten as a Trigger for PsychosisAlthough the role of food hypersensitivities in disease pathologies is highly controversial in the medical community, many recognize a parallel rise with dietary evolution in modern history.
Mycotoxin Induced Mitochondrial Dysfunction And Cytotoxicity
The following Q+A is a grouping of responses from Dr.
Metals – Toxic + Nutrient Elements Brochure
This brochure is designed to provide an overview of Metals – Toxic + Nutrient Elements.
MDX_Heavy-Metals_BrochureDownloadDownload available in the following languages:
MDX_Heavy-Metals_Brochure_JapaneseDownload MDX_Metals_Brochure_SpanishDownload MDX_Heavy-Metals_Brochure_FrenchDownload MDX_Heavy-Metals_Brochure_GermanDownload MDX_Heavy-Metals_Brochure_ItalianDownload MDX_Heavy-Metals_Brochure_PolishDownload MDX_Metals_Brochure_PortugueseDownload MDX_Heavy-Metals_Brochure_PolishDownload MDX_Metals_Brochure_HungarianDownloadStay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.